Envestnet Asset Management Inc. Buys 37 Shares of HCA Healthcare, Inc. (NYSE:HCA)

Envestnet Asset Management Inc. increased its stake in HCA Healthcare, Inc. (NYSE:HCA) by 0.0% in the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 175,701 shares of the company’s stock after buying an additional 37 shares during the period. Envestnet Asset Management Inc. owned 0.07% of HCA Healthcare worth $56,449,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also bought and sold shares of the business. FinTrust Capital Advisors LLC grew its holdings in HCA Healthcare by 26.7% in the fourth quarter. FinTrust Capital Advisors LLC now owns 166 shares of the company’s stock worth $45,000 after purchasing an additional 35 shares during the period. Lake Street Advisors Group LLC grew its holdings in shares of HCA Healthcare by 1.3% during the second quarter. Lake Street Advisors Group LLC now owns 2,732 shares of the company’s stock valued at $878,000 after buying an additional 35 shares during the last quarter. Financial Counselors Inc. grew its holdings in shares of HCA Healthcare by 1.4% during the first quarter. Financial Counselors Inc. now owns 2,642 shares of the company’s stock valued at $881,000 after buying an additional 36 shares during the last quarter. Premier Path Wealth Partners LLC grew its holdings in shares of HCA Healthcare by 2.7% during the second quarter. Premier Path Wealth Partners LLC now owns 1,393 shares of the company’s stock valued at $448,000 after buying an additional 36 shares during the last quarter. Finally, Westside Investment Management Inc. boosted its holdings in HCA Healthcare by 14.7% in the second quarter. Westside Investment Management Inc. now owns 289 shares of the company’s stock worth $93,000 after purchasing an additional 37 shares during the last quarter. Hedge funds and other institutional investors own 62.73% of the company’s stock.

Insider Activity at HCA Healthcare

In related news, SVP Kathryn A. Torres sold 1,857 shares of the company’s stock in a transaction dated Thursday, July 25th. The shares were sold at an average price of $355.05, for a total transaction of $659,327.85. Following the transaction, the senior vice president now directly owns 17,755 shares in the company, valued at approximately $6,303,912.75. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. In other HCA Healthcare news, SVP Christopher F. Wyatt sold 4,000 shares of the company’s stock in a transaction dated Monday, July 29th. The shares were sold at an average price of $360.20, for a total value of $1,440,800.00. Following the transaction, the senior vice president now directly owns 40,449 shares in the company, valued at approximately $14,569,729.80. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, SVP Kathryn A. Torres sold 1,857 shares of the company’s stock in a transaction dated Thursday, July 25th. The stock was sold at an average price of $355.05, for a total transaction of $659,327.85. Following the completion of the transaction, the senior vice president now owns 17,755 shares in the company, valued at $6,303,912.75. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 17,202 shares of company stock worth $6,407,273. Insiders own 1.60% of the company’s stock.

Analysts Set New Price Targets

HCA has been the topic of several recent research reports. Morgan Stanley initiated coverage on shares of HCA Healthcare in a research report on Tuesday, September 3rd. They issued an “equal weight” rating and a $427.00 price target on the stock. UBS Group increased their price target on shares of HCA Healthcare from $405.00 to $438.00 and gave the stock a “buy” rating in a research report on Wednesday, August 14th. Wolfe Research upgraded shares of HCA Healthcare to a “strong-buy” rating in a research report on Thursday, August 29th. Cantor Fitzgerald restated an “overweight” rating and set a $392.00 price objective on shares of HCA Healthcare in a research report on Monday, August 19th. Finally, Leerink Partners raised their price objective on shares of HCA Healthcare from $367.00 to $396.00 and gave the company an “outperform” rating in a research report on Wednesday, July 24th. Five research analysts have rated the stock with a hold rating, fourteen have assigned a buy rating and three have assigned a strong buy rating to the company’s stock. According to MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and a consensus target price of $359.89.

HCA Healthcare Stock Performance

HCA Healthcare stock opened at $399.89 on Thursday. The company’s 50-day moving average price is $367.24 and its 200-day moving average price is $339.56. HCA Healthcare, Inc. has a twelve month low of $215.96 and a twelve month high of $404.90. The company has a quick ratio of 0.94, a current ratio of 1.06 and a debt-to-equity ratio of 27.11. The company has a market cap of $104.74 billion, a PE ratio of 19.93, a price-to-earnings-growth ratio of 1.46 and a beta of 1.67.

HCA Healthcare (NYSE:HCA) last posted its earnings results on Tuesday, July 23rd. The company reported $5.50 earnings per share for the quarter, topping analysts’ consensus estimates of $4.97 by $0.53. HCA Healthcare had a net margin of 8.40% and a return on equity of 553.13%. The firm had revenue of $17.49 billion for the quarter, compared to the consensus estimate of $17.05 billion. During the same period in the previous year, the firm posted $4.29 EPS. The business’s quarterly revenue was up 10.3% on a year-over-year basis. On average, equities research analysts forecast that HCA Healthcare, Inc. will post 22.46 EPS for the current fiscal year.

HCA Healthcare Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Monday, September 30th. Investors of record on Monday, September 16th will be issued a dividend of $0.66 per share. The ex-dividend date is Monday, September 16th. This represents a $2.64 annualized dividend and a yield of 0.66%. HCA Healthcare’s payout ratio is 13.16%.

HCA Healthcare Company Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.